Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil

Transfusion

Volumn 52, Issue 4, 2012, Pages 870-879

  Sabino, Ester C ^a,b,c,d,e,f   Gonçalez, Thelma T ^a,b,c,d,e,f   Carneiro Proietti, Anna Bárbara ^a,b,c,d,e,f   Sarr, Moussa ^a,b,c,d,e,f   Ferreira, João Eduardo ^a,b,c,d,e,f   Sampaio, Divaldo A ^a,b,c,d,e,f   Salles, Nanci A ^a,b,c,d,e,f   Wright, David J ^a,b,c,d,e,f   Custer, Brian ^a,b,c,d,e,f   Busch, Michael ^a,b,c,d,e,f  

^a Pró Sangue Foundation Institute for Investigation in Immunology Iii INCT   (Brazil)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c Hemominas Foundation   (Brazil)

^d WESTAT   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f Hemope Foundation   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BRAZIL; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; VIRUS TRANSMISSION; WESTERN BLOTTING;

ADULT; AGED; BLOOD DONORS; BLOOD TRANSFUSION; BRAZIL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RISK;

EID: 84859751466     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03344.x     Document Type: Article

References (37)

1. Saude-DST/AIDS Md. Boletim epidemiologico AIDS DST boletim epidemiologico. Janeiro a Junho 2009, 2009.
2. Fonseca MG, Bastos FI,. Twenty-five years of the AIDS epidemic in Brazil: principal epidemiological findings, 1980-2005. Cad Saude Publica 2007; 23 (Suppl 3): S333-44.
3. Caiaffa WT, Bastos FI, Freitas LL, Mingoti SA, Proietti FA, Carneiro-Proietti AB, Gandolfi D, Doneda D, Projeto AjUDE-Brasil I, Projeto AjUDE-Brasil II. The contribution of two Brazilian multi-center studies to the assessment of HIV and HCV infection and prevention strategies among injecting drug users: the AjUDE-Brasil I and II Projects. Cad Saude Publica 2006; 22: 771-82.
4. Parker RG,. Civil society, political mobilization, and the impact of HIV scale-up on health systems in Brazil. J Acquir Immune Defic Syndr 2009; 52 (Suppl 1): S49-51.
5. Franca Junior I, Calazans G, Zucchi EM,. Changes in HIV testing in Brazil between 1998 and 2005. Rev Saude Publica 2008; 42 (Suppl 1): 84-97.
6. Goncalez TT, Sabino EC, Murphy EL, Chen S, Chamone DA, McFarland W,. Human immunodeficiency virus test-seeking motivation in blood donors, Sao Paulo, Brazil. Vox Sang 2006; 90: 170-6.
7. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE,. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000; 284: 229-35.
8. Seed CR, Kiely P, Keller AJ,. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Intern Med J 2005; 35: 592-8.
9. Suligoi B, Raimondo M, Regine V, Salfa MC, Camoni L,. Epidemiology of human immunodeficiency virus infection in blood donations in Europe and Italy. Blood Transfus 2010; 8: 178-85.
10. Likatavicius G, Hamers FF, Downs AM, Alix J, Nardone A,. Trends in HIV prevalence in blood donations in Europe, 1990-2004. AIDS 2007; 21: 1011-8.
11. Barreto CC, Sabino EC, Goncalez TT, Laycock ME, Pappalardo BL, Salles NA, Wright DJ, Chamone DF, Busch MP,. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in Sao Paulo, Brazil. Transfusion 2005; 45: 1709-14.
12. Germano FN, da Silva TM, Mendoza-Sassi R, Martinez AM,. High prevalence of users who did not return to the Testing and Counseling Center (TCC) for knowing their serological status: Rio Grande, RS, Brazil. Cien Saude Colet 2008; 13: 1033-40.
13. Carneiro-Proietti AB, Sabino EC, Sampaio D, Proietti FA, Gonçalez TT, Oliveira CD, Ferreira JE, Liu J, Custer B, Schreiber GB, Murphy EL, Busch MP,. Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008. Transfusion 2010; 50: 918-25.
14. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH, NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45: 254-64.
15. Sabino EC, Salles NA, de Almeida-Neto C, Barreto AM, Basques F, Barros EA, Mendrone A Jr, Busch MP, NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) and International Component. Performance of parallel screening of Brazilian blood donors with two human immunodeficiency virus immunoassays: implications for sequential immunoassay testing algorithms in other countries. Transfusion 2011; 51: 175-83.
16. Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, Busch MP,. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr 2003; 33: 349-55.
17. Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS, Hannon WH, Mei JV,. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 2003; 33: 625-34.
18. Keating SM, Lebedeva L, Laeyendecker O, Ali-Napo L, Contestable P, Edwards S, Ethridge S, Branson B, Norris PJ, Busch MP,. Optimization and calibration of less sensitive and avidity modified protocols for the vitros immunodiagnostic products anti-HIV-1+2 for detection of early HIV infections CDC/APHL diagnostic conference. Orlando, FL, 2010.
19. Kleinman SH, Lelie N, Busch MP,. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009; 49: 2454-89.
20. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G,. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 2003; 169: 767-73.
21. Lefrere JJ, Dahourouh H, Dokekias AE, Kouao MD, Diarra A, Diop S, Tapko JB, Murphy EL, Laperche S, Pillonel J,. Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study. Transfusion 2011; 51: 486-92.
22. Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I,. The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion 2010; 50: 433-42.
23. Szwarcwald CL, Castilho EA,. Estimated number of HIV-infected individuals aged 15-49 years in Brazil, 1998. Cad Saude Publica 2000; 16: 135-41.
24. Dodd RY, Notari EP, Stramer SL,. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975-9.
25. Goncalez T, Sabino E, Sales N, Chen YH, Chamone D, Busch M, Murphy E, Custer B, McFarland W,. Human immunodeficiency virus test-seeking blood donors in a large blood bank in Sao Paulo, Brazil. Transfusion 2010; 50: 1806-14.
26. Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, Rodriguez W, Rousseau C, Rehle TM, Welte A, Averill MD, Garcia Calleja JM, WHO Working Group on HIV Incidence Assays. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 2010; 24: 2763-71.
27. Pillonel J, Le Marrec N, Girault A, David D, Laperche S,. Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003. Transfus Clin Biol 2005; 12: 239-46.
28. WHO. Universal Access to Safe Blood [monograph on the internet ]. 2009. [cited 2011 Aug 29]. Available from: URL
29. WHO. Screening Donated Blood for Transfusion-Transmissible Infections [monograph on the internet ]. 2009. [cited 2011 Aug 29]. Available from: URL
30. Allain JP, Sarkodie F, Asenso-Mensah K, Owusu-Ofori S,. Relative safety of first-time volunteer and replacement donors in West Africa. Transfusion 2010; 50: 340-3.
31. Mbanya DN,. Volunteer or family/replacement donations: are the tides changing? Transfusion 2010; 5: 1849-50.
32. Andre L,. Relatively safety of first-time volunteer and replacement donors in Guinea. Transfusion 2010; 5: 1850-51.
33. Pereira A, Sanz C, Tassies D, Ramirez B,. Do patient-related blood donors represent a threat to the safety of the blood supply? Haematologica 2002; 87: 427-33.
34. de Almeida Neto C, McFarland W, Murphy EL, Chen S, Nogueira FA, Mendrone A Jr, Salles NA, Chamone DA, Sabino EC,. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria. Transfusion 2007; 47: 608-14.
35. Lau JT, Thomas J, Lin CK,. HIV-related behaviours among voluntary blood donors in Hong Kong. AIDS Care 2002; 14: 481-92.
36. Lefrere JJ, Elghouzzi MH, Paquez F, N'Dalla J, Nubel L,. Interviews with anti-HIV-positive individuals detected through the systematic screening of blood donations: consequences on predonation medical interview. Vox Sang 1992; 62: 25-8.
37. Goncalez TT, Sabino EC, Salles NA, de Almeida-Neto C, Mendrone A Jr, Dorlhiac-Laccer PE, Liu J, Murphy EL, Schreiber GB, REDS-II International Brazil Study. The impact of simple donor education on donor behavioral deferral and infectious disease rates in Sao Paulo, Brazil. Transfusion 2010; 50: 909-17.